This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
-
David Berman, Teaching Note
Raman, Ananth; Gaur, Vishal; Kesavan, SaravananTeaching Note HBS-609006-EService and Operations ManagementTeaching Note for [605081].Starting at €0.00
-
Rajat Gupta, Teaching Note
Healy, Paul M.; Soltes, EugeneTeaching Note HBS-117068-ETeaching Note for HBS Case No.117-004, "Rajat Gupta"Starting at €0.00
-
Valuation at Novartis
Healy, Paul M.Case HBS-108041-EFinanceAn abstract is not available for this product.Starting at €8.20
-
Oddo Securities - ESG Integration
Serafeim, George; Healy, Paul M.; Sesia, AldoCase HBS-111085-EThe case describes the process of integrating environmental, social, and governance issues into valuation models and research analyst recommendations.Starting at €8.20
-
Eddie Bauer (B)
Healy, Paul M.; Katz, Sharon; Sesia, AldoCase HBS-110009-EAccounting and ControlIn February 2007, shareholders of Eddie Bauer, the specialty apparel retailer, were scheduled to vote on management's proposed sale of the company to two private equity firms. More than 50% of outstanding shares in Eddie Bauer needed to be voted in favor of the deal for it to be finalized. Shareholders needed to decide whether to vote for or against the proposed sale, which was fully endorsed by the board of Eddie Bauer.Starting at €5.74
-
Airbus A380--Turbulence Ahead
Raman, Ananth; Schmidt, William; Gaur, VishalCase HBS-609041-EMultiple delays of the Airbus A380 have shocked analysts and investors alike. What are the causes of these delays and how should investors respond to the signals they may be sending about the company's outlook?Starting at €8.20
-
-
Coca-Cola in Vietnam
Goh, Joel; Raman, AnanthCase HBS-616063-EService and Operations ManagementStarting at €8.20
-
Merck: Operating Science-Based Business
Raman, Ananth; Maurer, Inga; Schmidt, WilliamCase HBS-612082-EService and Operations ManagementMerck is known for its commitment to investing in basic R&D. Are Merck's long-term investments justifiable when the firm faces extreme earnings pressure?Starting at €8.20